98 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
harbor provisions of the Private Securities Litigation Reform Act of 1995.
GOSSAMER BIO, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENT DATA
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
8-K
EX-99.1
GOSS
Gossamer Bio Inc
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Gossamer
424B3
xbspjl8yhr436
28 Aug 23
Prospectus supplement
4:29pm
S-3
nid2wiraev0d
18 Aug 23
Shelf registration
8:41am
S-3ASR
nh31s e2el
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
wnr9 vh6dfjjq75ky5wg
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
xkorjjnufjblpvm
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
2i8tibe3 1qh4
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-10.1
2zr 8gdgvwknzyoo9
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
q3gue n2l
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
tatetzowki6pntg s7ir
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
PRE 14A
cvq6z0ymc2m b28
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.1
28nl4 onm
6 Dec 22
Other Events
7:36am
8-K
0ywpyk7v
6 Dec 22
Other Events
7:36am